Novartis to Buy Myricx Bio for Up to $1.5 Billion
The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis’s oncology capabilities.
The Source
TWSJ
Entertainment
From $200 Loans to $30,000 Birkins, a Pawnshop Chain Serves the K-Shaped Economy
TWSJ·1d ago·3 min read
Entertainment
Two Banks Agreed to Merge. They Can’t Agree on How to Make Chili.
TWSJ·1d ago·3 min read
Entertainment
Italy’s Eni Invests $225 Million in U.S. Startup EnergyX’s Chile Lithium Project
TWSJ·1d ago·3 min read
Entertainment
France’s Thales to Take Stake in Maritime Drone Maker Exail Ahead of Takeover
TWSJ·1d ago·3 min read
Related
On this beat
Entertainment
LTC Price Prediction: Whales Are Loaded Long, But the $46–$47 Wall Decides Everything
BN·1d ago·3 min read
Entertainment
TRX Price Prediction: Expect a $0.31 Flush Before Bulls Get Their Breakout
BN·1d ago·3 min read
Entertainment
XLM Price Prediction: Coiled at $0.20 — Smart Money Is Quietly Building a Position
BN·1d ago·3 min read
Entertainment
I’ve spent 20 years teaching people to communicate. Phone anxiety has never been worse.
BI·1d ago·3 min read
